Document is current
Any future updates will be listed below
-
Authors
Shen, Ning
Lu, Shangwei
Kong, Zhijuan
Gao, Ying
Hu, Jinxiu
Si, Shuxuan
Wang, Junlin
Li, Jie
Han, Wei
Wang, Rong
Lv, Zhimei
-
Funding
Funding for this research was provided by:
Shandong Province Natural Science Foundation Joint Fund (No. ZR2022LSW020)
National Natural Science Foundation of China (82370721)
National Natural Science Foundation of China (81873615)
Taishan Scholars Program (ts201712090)
Taishan Scholars Program (tsqn201812138)
- License Information
-
More Information
Article History
Received: 9 April 2024
Accepted: 21 June 2024
First Online: 16 July 2024
Declarations
:
: About research on immune cells, all participants signed informed consent to study protocols approved by the Sardinian Regional Ethics Committee (protocol no. 2171/CE). All studies were approved by local ethics committees, and all participants provided written, informed consent. Informed consent was obtained from all participants and/or their LAR. The study of metabolite was approved by the research ethics boards of the Jewish General Hospital, protocol number 2021-2762.
: All authors have read the manuscript and approved its submission to the Diabetology and Metabolic Syndrome.
: The authors declare no competing interests.
